Author:
Habibzadeh Parham,Nemati Azim,Dastsooz Hassan,Taghipour‐Sheshdeh Afsaneh,Paul Prisho Mariam,Sahraian Ali,Faghihi Mohammad Ali
Publisher
Springer Science and Business Media LLC
Reference106 articles.
1. Abi-Dargham A., Rodenhiser J., Printz D., Zea-Ponce Y., Gil R., Kegeles L. S. et al. 2000 Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Natl. Acad. Sci. USA 97, 8104–8109.
2. Alfimova M. V., Golimbet V. E., Korovaitseva G. I., Aksenova E. V., Lezheiko T. V., Abramova L. I. et al. 2014 Association of the COMT and DRD2 genes with the ability of schizophrenia patients to understand the mental state of other people. Neurosci. Behav. Physiol. 45, 12–18.
3. Alfimova M. V., Kondratyev N. V., Tomyshev A. S., Lebedeva I. S., Lezheiko T. V., Kaleda V. G. et al. 2019 Effects of a GWAS-supported schizophrenia variant in the DRD2 locus on disease risk, anhedonia, and prefrontal cortical thickness. J. Mol. Neurosci. 68, 658–666.
4. Arab A. H. and Elhawary N. A. 2015 Association between ANKK1 (rs1800497) and LTA (rs909253) genetic variants and risk of schizophrenia. Biomed. Res. Int. 2015, 821827.
5. Arinami T., Itokawa M., Enguchi H., Tagaya H., Yano S., Shimizu H. et al. 1994 Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 343, 703–704.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献